ACIP's Thimerosal Vote: The Committee Has Lost Its Value to Medicine – RamaOnHealthcare

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.

ACIP Votes to Remove Thimerosal from Influenza Vaccines - LewRockwell

Click here: The MAHA Report   The post ACIP Votes to Remove Thimerosal from Influenza Vaccines appeared first on LewRockwell.

Weekly review: ACIP meets and votes, marstacimab data for hemophilia, and more

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

ACIP's Thimerosal Vote: The Committee Has Lost Its Value to Medicine – RamaOnHealthcare

While the vote won't impact U.S. vaccine delivery, it has broader implicationsI have often wondered how civilizations slide backward, turn their backs, and discard scientific and technological achievements. Is it all at once, is it by dribs and drabs, or is it by default when no one is there to defend it? The recent meeting [...]

Thimerosal Reenters Public Debate as ACIP Scrutinizes Use in Influenza Vaccines

With the Advisory Committee on Immunization Practices recommending that adults receive thimerosal-free influenza vaccines, the preservative that was phased out of most childhood vaccines in 2001 has reentered the public eye.

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.